By Hugo Francisco de Souza Reviewed by Susha Cheriyedath, M.Sc. As cancer medicine becomes increasingly data-intensive, researchers explore how generative AI could help oncologists interpret genomic mutations, identify clinical trials, and synthesize complex patient data while maintaining strict human oversight. In a recent narrative review published in the Journal of Hematology & Oncology, researchers synthesized […]
Source